MMP9 and migraine disorder: It has been suggested that MMP-9 levels, which were known to peak during the 3rd day of the attack, could be used as a biomarker in migraine (Gursoy Ozdemir et al., 2004), and inhibition of MMP-9 might be an alternative target in treatment (Gupta 2009).